Evidence Hub

Acute treatment of migraine in children and adolescents: review of the American Academy of Neurology Practice guideline update

D. Cromb, D. Grigoratos

Archives of Disease in Childhood, 2020

1 citation

Abstract

Migraine is a brain disease that involves episodes of medium to severe headaches along with specific associated symptoms, including nausea, vomiting, photophobia and phonophobia, as defined by criteria developed by the International Headache Society. It is a common and disabling condition in children, estimated to affect ~10% of girls and ~6% of boys1 and it accounts for ~2% of visits to the emergency department in the USA.2 Migraines can disrupt life activities, such as participation in home, school and social functions, and can have a negative effect on quality of life. They can also be challenging to manage. This review aims to summarise the latest evidence-based information for the acute treatment of migraines. Prophylactic treatment options for migraine are outside the scope of this article and will not be addressed here.

### Information about the current guideline

The aim of the American Academy of Neurology (AAN) guideline is to provide evidence-based recommendations for the acute symptomatic treatment of children and adolescents with migraine, for use by healthcare practitioners, patients and their families (see box 1).

Box 1

### Resources

American Academy of Neurology (AAN) practice guideline update summary: acute treatment of migraine in children and adolescents

Other useful resources for the investigation and management of migraine in children and adolescents:

The guideline was approved by the AAN Guideline Development Dissemination …

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free